176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.25%
Revenue growth above 1.5x AMD's 12.03%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
30.11%
Gross profit growth above 1.5x AMD's 13.99%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
114.75%
EBIT growth above 1.5x AMD's 21.54%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
114.75%
Operating income growth above 1.5x AMD's 15.04%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
114.79%
Net income growth above 1.5x AMD's 30.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
116.00%
EPS growth above 1.5x AMD's 31.03%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
112.00%
Diluted EPS growth above 1.5x AMD's 29.31%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.32%
Share count expansion well above AMD's 0.53%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.64%
Slight or no buyback while AMD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.32%
Dividend reduction while AMD stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-18.38%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-40.30%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
423.15%
10Y revenue/share CAGR above 1.5x AMD's 51.17%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
217.61%
5Y revenue/share CAGR above 1.5x AMD's 117.73%. David Dodd would look for consistent product or market expansions fueling outperformance.
74.94%
3Y revenue/share CAGR at 50-75% of AMD's 140.28%. Martin Whitman would question if the firm lags behind competitor innovations.
463.12%
10Y OCF/share CAGR above 1.5x AMD's 166.09%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
339.89%
Below 50% of AMD's 1831.64%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
7.86%
3Y OCF/share CAGR under 50% of AMD's 723.00%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1370.70%
Net income/share CAGR above 1.5x AMD's 463.66% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
376.30%
5Y net income/share CAGR above 1.5x AMD's 250.00%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
55.56%
Below 50% of AMD's 733.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
394.32%
10Y equity/share CAGR above 1.5x AMD's 142.38%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
201.19%
Below 50% of AMD's 1122.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
135.54%
Below 50% of AMD's 484.14%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
63.82%
Dividend/share CAGR of 63.82% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
15.00%
3Y dividend/share CAGR of 15.00% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
22.17%
AR growth well above AMD's 10.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.71%
Inventory growth well above AMD's 7.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.76%
Asset growth above 1.5x AMD's 4.32%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
9.85%
BV/share growth above 1.5x AMD's 0.47%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.69%
We’re deleveraging while AMD stands at 5.24%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.02%
R&D dropping or stable vs. AMD's 16.08%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-17.86%
We cut SG&A while AMD invests at 7.92%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.